drug

gepirone hydrochloride ER

Marketedupdated 2mo ago

by Fabre-Kramer Pharmaceuticals Inc

Approved

community read0 votes

indications

investigational

Major Depression

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 25m ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Sep 22, 2028

~2.2 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Sep 2, 2030method-of-use (U-3699)US 75381164.1y
Sep 2, 2030method-of-use (U-3699)US 75381164.1y
Sep 2, 2030method-of-use (U-3699)US 75381164.1y
Sep 2, 2030method-of-use (U-3699)US 75381164.1y

FDA exclusivities (4)

Sep 22, 2028NCENew Chemical Entity (5y)2.2y
Sep 22, 2028NCENew Chemical Entity (5y)2.2y
Sep 22, 2028NCENew Chemical Entity (5y)2.2y
Sep 22, 2028NCENew Chemical Entity (5y)2.2y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?